The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...
So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
A Flushing ketamine trafficking operation was dismantled after a Queens grand jury indicted four individuals on conspiracy, ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
They've found recreational use has grown dramatically over the past decade. It increased more than 80 percent from 2015 to ...